Dr. Erich Hunziker is a Chairman-Supervisory Board at BB Biotech AG, a Chairman-Supervisory Board at Discoveric AG, a Chairman-Supervisory Board at discoveric bio alpha AG, a Chairman-Supervisory Board at discoveric bio beta AG, a Chairman-Supervisory Board at discoveric marina AG, a Chairman-Supervisory Board at Entsia International AG, a Chairman-Supervisory Board at Light Chain Biosciences AG and a Chairman-Supervisory Board at Novimmune SA. He is on the Board of Directors at EngMab SARL, International Institute for Management Development, Lamkap Bio Alpha AG, LamKap Bio beta AG, LamKap Bio beta AG and Lamkap Bio Gamma AG. Dr. Hunziker was previously employed as a Chief Financial & Information Technology Officer by Roche Holding AG, a Chief Financial Officer by F. Hoffmann-La Roche Ltd., a Chief Executive Officer by Diethelm Keller Holding AG, a Deputy Chairman by Holcim Ltd., a Chief Financial Officer by Roche Diagnostics GmbH, a Chief Financial Officer by Corange Ltd., a Vice Chairman by Roche Holdings, Inc., and a Chief Financial Officer by Roche Ventures. He also served on the board at Chugai Pharmaceutical Co., Ltd., Genentech, Inc., AB2 Bio SA and Pharmaq Holding AS. He received his doctorate degree from Swiss Federal Institute of Technology.